$REGN with a bullish outlook following its earnings #Stocks Long
Regeneron Pharmaceuticals, Inc.NASDAQ
Description
⋅ The PEAD projected a bullish outlook for NASDAQ:REGN after a negative under reaction following its earnings release placing the stock in drift D .